期刊文献+

尼美舒利致幼儿溶血性贫血 被引量:1

Hemolytic anemia due to nimesulide in a child
原文传递
导出
摘要 1例5岁女性患儿因发热口服其家长自行购买的尼美舒利颗粒50 mg,服药后约16 h出现腹痛及洗肉水样血尿。因发热再次服用尼美舒利颗粒50 mg,服药后约3 h后前述症状复现。实验室检查示外周血白细胞计数 (WBC) 24.5×10^9/L,中性粒细胞计数 (NEU) 14.5×10^9/L,红细胞计数(RBC)1.6×10^12/L,血红蛋白(Hb) 55.0 g/L,血小板计数 (PLT)193×10^9/L。外院诊断为溶血性贫血,给予人免疫球蛋白、地塞米松输液治疗5 d后患儿尿液颜色变浅,RBC升至2.7×10^12/L,Hb升至83.0 g/L。发病第7天入我院,血常规检查示WBC 18.7×10^9/L, NEU 10.5×10^9/L,RBC 2.8×10^12/L,Hb 93.0 g/L,PLT 521×10^9/L,网织红细胞计数 (Ret) 320×10^9/L。给予阿奇霉素抗感染及地塞米松、谷胱甘肽等对症治疗10 d后复查血常规示WBC 17.2×10^9/L, NEU 12.6×10^9/L,RBC 3.5×10^12/L,Hb 114.0 g/L,PLT 575×10^9/L,Ret 150×10^9/L。患儿未再出现血尿。 A 5-year-old girl with fever received nimesulide granules 50 mg which was bought by her parents. Sixteen hours later she developed abdominal pain and gross hematuria. She received nimesulide granules 50 mg again because of fever. About 3 hours later the above-mentioned symptoms recurred. Laboratory tests showed the following values: white blood cell count (WBC) 24.5×10^9/L, Neutrophil count (NEU) 14.5×10^9/L, red blood cell count (RBC) 1.6×10^12/L, and hemoglobin (Hb) 193×10^9/L. She was diagnosed as hemolytic anemia in the other hospital and received the fluid therapy and human immune globulin and dexamethasone for 5 days. Then her urine color turned light, RBC and Hb increased to 2.7×10^12/L and 83.0 g/L, respectively. One day 7 of morbidity she was hospitalized in our hospital. Blood routine examination showed the following values: WBC 18.7×10^9/L, NEU 10.5×10^9/L, RBC 2.8×10^12/L, Hb 93.0 g/L, PLT 521×10^9/L,and absolute value of reticulocyte (Ret) 320×10^9/L. She received azithromycin for infection, and symptomatic treatment (dexamethasone and glutathione). Ten days later, the blood routine examination showed: WBC 17.2×10^9/L, NEU 12.6×10^9/L, RBC 3.5×10^12/L, Hb 114.0 g/L, PLT 575×10^9/L and Ret 150×10^9/L. Hematuria did not occur again in this patient.
作者 刘亮 王继美
出处 《药物不良反应杂志》 CSCD 2015年第5期396-397,共2页 Adverse Drug Reactions Journal
关键词 贫血 溶血性 尼美舒利 Anemia, hemolytic Nimesulide
  • 相关文献

参考文献10

  • 1尼美舒利在3个欧洲国家停止销售[J].药物不良反应杂志,2002,4(4):230-230. 被引量:11
  • 2WHO pharmaceuticals newsletter: Nimesulide-containing productsfor oral use-marketing suspended in Ireland due to reports of liverfailure[EB/OL]. 2007-05-21. http://www. who. int.
  • 3EMEA. European Medicines Agency recommends restricted use ofnimesulidecontaining medicinal products [ EB/OL ]. 2007-9-21.http ;//www. ema. europa. eu/ema/.
  • 4中国食品药品监督管理局.关于加强尼美舒利口服制剂使用管理的通知[EB/OL]. 2011-05-15. http://www. sda. gov. cn/WS01/CL0844/62434. html.
  • 5于荣华.尼美舒利致肝严重不良反应回顾性分析[J].中国医药导报,2008,5(9):175-175. 被引量:8
  • 6韩松瑛,刘树森,玄延花,任香善,宋京郁,林贞花.尼美舒利引起严重肝损伤致死尸检1例[J].临床与实验病理学杂志,2008,24(4):508-509. 被引量:8
  • 7Licata A, Calvaruso V, Cappello M, et al. Clinical course andoutcomes of drug-induced liver injury : nimesulide as the firstimplicated medication[ J]. Dig Liver Dis, 2010,42(2) : 143-148.
  • 8Srivatsa A, Bharti B, Singhi SC. Does nimesulide induce hae-molysis in glucose-6-phosphate dehydrogenase deficiency? [ J ].ActaPaediatr, 2003,92(5) : 637-638.
  • 9钱崇付,梁小丽,何璐璐.尼美舒利致儿童溶血性贫血[J].药物不良反应杂志,2012,14(3):174-175. 被引量:2
  • 10Rodrigo L, de Francisco R, Perez-Pariente JM, et al. Nimesulide-induced severe hemolytic anemia and acute liver failure leading toliver transplantation[ J]. Scand J Gastroenterol,2002,37 (11):1341-1343.

二级参考文献19

  • 1吴健鸿,曾繁典.尼美舒利肝不良反应再评价[J].药物流行病学杂志,2005,14(3):144-147. 被引量:12
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 3王临旭,王九平,黄长形.尼美舒利致儿童急性重型肝炎死亡[J].药物不良反应杂志,2007,9(2):130-131. 被引量:22
  • 4张莉,樊成辉.尼美舒利片引起肝功能损害、上消化道出血1例[J].中国药物应用与监测,2007,4(2):63-64. 被引量:6
  • 5陈瑶,李岚.尼美舒利致肝功能损伤1例[J].海峡药学,2007,19(7):114-115. 被引量:6
  • 6Dastis S N, Rahier J, Lerut J, et al. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound [ J ]. Eur J Gastroenterol Hepatol, 2007,19( 11 ) :912 -922.
  • 7Saha K. Use of nimesulide in Indian children must be stopped[ J]. BMJ,2003,326 (29) :713.
  • 8Mingatto F B, Rodrigues T, Pigoso A A, et al. The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes[ J]. J Pharmacol Exp Ther,2002,303 ( 2 ) :601 - 607.
  • 9Berson A, Cazanave S, Descatoire V, et al. The anti-intlarrmlatory drug, nimesulide ( 4-nitro-2-phenoxymethane-sulfoanilide ), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells:protection by albumin [ J ]. J Pharmacol Exp Ther,2006,318( 1 ) :444 -454.
  • 10Trumper L, Coux G, Monasterolo L A, et al. Effect of acetaminophen on the membrane anchoring of Na^+ , K^+ ATPase of rat renal cortical cells[ J]. Biochem Biophys Acta, 2005,1740 ( 3 ) : 332 - 339.

共引文献24

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部